Reply: Evidence of Recent Genomic Evolution in Gonococcal Strains With Decreased Susceptibility to Cephalosporins or Azithromycin in the United States, 2014-2016

J Infect Dis. 2020 Feb 18;221(5):852-853. doi: 10.1093/infdis/jiz505.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.
  • Comment

MeSH terms

  • Azithromycin* / pharmacology
  • Cephalosporins / pharmacology
  • Evolution, Molecular
  • Gonorrhea* / drug therapy
  • Gonorrhea* / epidemiology
  • Humans
  • Neisseria gonorrhoeae / genetics
  • United States / epidemiology

Substances

  • Cephalosporins
  • Azithromycin